Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Pantoprazole infusion as adjuvant therapy to endoscopic treatment in patients with peptic ulcer bleeding: Prospective randomized controlled trial
2006
A compressed sensing technique for OFDM channel estimation in mobile environments: Exploiting channel sparsity for reducing pilots
2008
Optimal dose of intravenous pantoprazole in patients with peptic ulcer bleeding requiring endoscopic hemostasis in Korea
2009
Reactive Oxygen Species and the Central Nervous System
1992 Standout
Clinically Important Drug Interactions with Anticoagulants
1996
Pharmacogenetics of the Proton Pump Inhibitors: A Systematic Review
2003
1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine Monofumarate (TAK-438), a Novel and Potent Potassium-Competitive Acid Blocker for the Treatment of Acid-Related Diseases
2010
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
2008 Standout
Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism
2002
Albumin–drug interaction and its clinical implication
2013 Standout
A Study Comparing the Antisecretory Effect of TAK-438, a Novel Potassium-Competitive Acid Blocker, with Lansoprazole in Animals
2011
High‐dose intravenous proton pump inhibition following endoscopic therapy in the acute management of patients with bleeding peptic ulcers in the USA and Canada: a cost‐effectiveness analysis
2004
Lack of interaction between meloxicam and warfarin in healthy volunteers
1997
Selective deep hypothermia of the spinal cord prevents paraplegia after aortic cross-clamping in the dog model
1992
Helicobacter pylori Reduces Intracellular Glutathione in Gastric Epithelial Cells
2000
Nonconvulsive status epilepticus in adults — insights into the invisible
2016
Effect of aprepitant on the pharmacokinetics and pharmacodynamics of warfarin
2005
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
2007 Standout
Adverse Effects of Long-Term Proton Pump Inhibitor Therapy
2011
Deep convolutional neural network for the automated detection and diagnosis of seizure using EEG signals
2017 Standout
Effects of Mitemcinal (GM-611), an Acid-Resistant Nonpeptide Motilin Receptor Agonist, on the Gastrointestinal Contractile Activity in Conscious Dogs
2007 StandoutNobel
Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture
2006 Standout
Clinically Significant Pharmacokinetic Interactions Between Dietary Caffeine and Medications
2000
Influence of a Fat-Rich Meal on the Pharmacokinetics of a New Oral Formulation of Cyclosporine in a Crossover Comparison with the Market Formulation
1994
Effect of the catechol‐O‐methyltransferase inhibitor entacapone on the steady‐state pharmacokinetics and pharmacodynamics of warfarin
2002
Comparison of p.o. or i.v. proton pump inhibitors on 72‐h intragastric pH in bleeding peptic ulcer
2009
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
Esomeprazole — enhanced bio‐availability, specificity for the proton pump and inhibition of acid secretion
2003
Intravenous pantoprazole versus ranitidine for prevention of rebleeding after endoscopic hemostasis of bleeding peptic ulcers
2004
Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2
2009
Management of Patients With Ulcer Bleeding
2012 Standout
Spinal oxygenation, blood supply localization, cooling, and function with aortic clamping
1992
Internal hazards: baseline DNA damage by endogenous products of normal metabolism
1999
Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirin
2008 Standout
Lack of a Clinically Significant Pharmacokinetic Interaction between Fenofibrate and Pravastatin in Healthy Volunteers
2000
Systematic Overview of Warfarin and Its Drug and Food Interactions
2005 Standout
Evolving Concepts in Prevention of Spinal Cord Injury during Operations on the Descending Thoracic and Thoracoabdominal Aorta
1987
Clinical Pharmacology of Tramadol
2004 Standout
A Novel Placement Method of the Bravo Wireless pH Monitoring Capsule for Measuring Intragastric pH
2008
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2009 Standout
Coffee and Health: A Review of Recent Human Research
2006 Standout
RANDOMIZED TRIAL COMPARING PANTOPRAZOLE INFUSION, BOLUS AND NO TREATMENT ON GASTRIC pH AND RECURRENT BLEEDING IN PEPTIC ULCERS
2007
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Continuous Infusion of Pantoprazole versus Ranitidine for Prevention of Ulcer Rebleeding: A U.S. Multicenter Randomized, Double-Blind Study
2006
Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
2017 Standout
Effects of pumaprazole (BY841), a novel reversible proton pump antagonist, and of omeprazole, on intragastric acidity before and after cure of Helicobacter pylori infection
1999
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding
2010 Standout
Lack of effect of pantoprazole on the pharmacodynamics and pharmacokinetics of warfarin [see comments]
1995
Lack of Interaction Between Tramadol and Coumarins
1998
A Preliminary Study on Waveform Candidates for 5G Mobile Radio Communications above 6 GHz
2016
Prevention of Reperfusion Injury of the Ischemic Spinal Cord: Use of Recombinant Superoxide Dismutase
1986
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
A placebo‐controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24‐h intragastric acidity and plasma gastrin concentrations in young healthy male subjects
1998
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Millimeter-Wave Cellular Wireless Networks: Potentials and Challenges
2014 Standout
Experience with 1509 patients undergoing thoracoabdominal aortic operations
1993 Standout
Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy
2013
Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding
2010
What Will 5G Be?
2014 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
OFDM Versus Filter Bank Multicarrier
2011 Standout
Chemistry of Covalent Inhibition of the Gastric (H+, K+)-ATPase by Proton Pump Inhibitors
2004
A Multivariate Approach for Patient-Specific EEG Seizure Detection Using Empirical Wavelet Transform
2017
Heavy Metals and Human Health: Mechanistic Insight into Toxicity and Counter Defense System of Antioxidants
2015 Standout
Cosine Modulated and Offset QAM Filter Bank Multicarrier Techniques: A Continuous-Time Prospect
2010
5G: A Tutorial Overview of Standards, Trials, Challenges, Deployment, and Practice
2017 Standout
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Spinal cord injury following surgical correction of acute aortic disruption.
1992
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
A Survey on Multicarrier Communications: Prototype Filters, Lattice Structures, and Implementation Aspects
2014
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
2004 Standout
Latency Critical IoT Applications in 5G: Perspective on the Design of Radio Interface and Network Architecture
2017 Standout
Selective deep hypothermia of the spinal cord prevents paraplegia after aortic cross-clamping in the dog model
1992
Mutation of the gastric hydrogen-potassium ATPase alpha subunit causes iron-deficiency anemia in mice
2011 StandoutNobel
Engineering of Kuma030: A Gliadin Peptidase That Rapidly Degrades Immunogenic Gliadin Peptides in Gastric Conditions
2015 StandoutNobel
Works of M. Hartmann being referenced
Prospective multi-center study of an automatic online seizure detection system for epilepsy monitoring units
2014
Lack of pharmacokinetic interaction of pantoprazole with diazepam in man
1996
Intragastric Ph During Continuous Infusion With Pantoprazole in Patients With Bleeding Peptic Ulcer
2003
Rhythmic and periodic EEG patterns of ‘ictal–interictal uncertainty’ in critically ill neurological patients
2015
Differences in pH-Dependent Activation Rates of Substituted Benzimidazoles and Biological in vitro Correlates
1998
Single intravenous administration of the H+, K+‐ATPase inhibitor BY 1023/SK&F 96022—inhibition of pentagastrin‐stimulated gastric acid secretion and pharmacokinetics in man
1990
Toxicokinetics of isoprene in rodents and humans
1996
Lack of pharmacodynamic and pharmacokinetic interaction between pantoprazole and phenprocoumon in man
1996
Pantoprazole lacks induction of CYP1A2 activity in man.
1999
Pharmacokinetics of pantoprazole in man.
1996
Prevention of paraplegia during aortic operations
1990
Twenty‐four‐hour intragastric pH profiles and pharmacokinetics following single and repeated oral administration of the proton pump inhibitor pantoprazole in comparison to omeprazole.
1996
Lack of pharmacokinetic interaction as an equivalence problem.
1991
Lack of pantoprazole drug interactions in man: an updated review.
1996
Analysis, Optimization, and Implementation of Low-Interference Wireless Multicarrier Systems
2007
Current status of acid pump antagonists (reversible PPIs).
1997
Pantoprazole lacks interaction with antipyrine in man, either by inhibition or induction.
1994
The reversible H+,K+-ATPase-antagonist by 841 is more effective in elevating gastric pH in helicobater pylori positive than in Hp-negative volunteers
1998
Pentagastrin-stimulated gastric acid secretion and pharmacokinetics following single and repeated intravenous administration of the gastric H+, K(+)-ATPase-inhibitor pantoprazole (BY1023/SK&F96022) in healthy volunteers.
1990
Direct measurements of oxygen tension on the spinal cord surface of pigs after occlusion of the descending aorta
1985
Lack of influence of pantoprazole on the disposition kinetics of theophylline in man.
1991
Optimizing the intragastric pH as a supportive therapy in upper GI bleeding.
1997